🎙️
AIPodify

The All-In Podcast

Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like

Guest: Bryan JohnsonMarch 26, 2026
Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like

Episode Summary

AI-generated · Mar 2026

AI-generated summary — may contain inaccuracies. Not a substitute for the full episode or professional advice.

Bryan Johnson, known for his radical anti-aging regimen "Project Blueprint," joins the All-In podcast to share his groundbreaking experience with 5-MeO-DMT, the most powerful psychedelic known. He reveals that just 48 hours prior to the interview, he underwent a high-dose session, not for recreation or typical therapeutic reasons, but as a deliberate longevity experiment, building on earlier, quantified psilocybin trials that showed a "dramatic restoration of youthful brain patterns" and a "metabolic reset." Johnson's central thesis is that psychedelics, particularly 5-MeO-DMT, offer unparalleled "psychological rejuvenation" and neuroplasticity that other longevity interventions cannot achieve.

Johnson describes the 5-MeO-DMT experience as an "impossible task to explain," but attempts to convey it as encountering "raw consciousness and raw intelligence." He explains that it hits within 10 seconds, dissolving the "default mode network" (DMN)—the brain's engine for ego and rumination—and forcing a choice: resist or "relent and say yes." Surrendering led to "unimaginable bliss and euphoria," which he asserts was "without question the most dynamic experience I’ve ever experienced as a human." He notes that unlike DMT, it is not a visual experience but rather a profound, visceral immersion in the "depths of existence."

Post-experience, Johnson reports feeling "childlike," with a renewed sense of excitement, an improved ability to manage relational conflict without ego or defensiveness, and a more immediate sense of humor. He emphasizes that 5-MeO-DMT "annihilated" his DMN, leading to a "new map of connectivity" and neuroplasticity, which he suggests could be crucial for adapting to a rapidly changing world driven by AI, framing "psychoflexibility" as an asset. While acknowledging the significant risks of psychedelics, including psychosis and radical life changes, Johnson advocates for rigorous, quantified, and professionally supervised approaches to maximize safety and benefits.

Beyond psychedelics, Johnson also details his exploration of future "next-gen" longevity therapies, including mitochondrial augmentation therapy (with plans to receive it soon, potentially from a younger family member's cells), gene therapy (expressing foxil 3 for tissue rejuvenation), and the creation of "Bryan Johnson organoids" (heart, liver, lungs from his own induced pluripotent stem cells) to test drug efficacy and side effects in vitro. The episode concludes with Johnson asserting that while diet, exercise, and sleep are beneficial, nothing has matched 5-MeO-DMT's impact on his "reset of me as a human" and its unique ability to restore a youthful disposition and "can do attitude" that typically diminishes with age.

👤 Who Should Listen

  • Individuals interested in extreme longevity protocols and biohacking.
  • Researchers and enthusiasts exploring the therapeutic potential and risks of powerful psychedelics like 5-MeO-DMT.
  • Anyone grappling with concepts of self, consciousness, and the impact of radical personal transformation.
  • Entrepreneurs and investors considering the ethical and practical implications of advanced biotechnologies like gene and cell therapies.
  • People curious about the Default Mode Network and its role in aging, mental well-being, and adaptation to change.
  • Those interested in how profound subjective experiences can be quantified and integrated into scientific study for anti-aging.

🔑 Key Takeaways

  1. 1.Bryan Johnson underwent a high-dose 5-MeO-DMT session as a longevity experiment, following prior psilocybin trials that showed "dramatic restoration of youthful brain patterns" and a "metabolic reset" [01:00, 14:11, 09:07].
  2. 2.He describes the 5-MeO-DMT experience as encountering "raw consciousness and raw intelligence," dissolving the default mode network (DMN), and leading to "unimaginable bliss and euphoria" after surrendering to the experience [02:29, 04:36].
  3. 3.5-MeO-DMT "completely dissolves your default mode network," unlike psilocybin which dampens it, leading to profound neuroplasticity and a "new map of connectivity" in the brain [06:07, 10:02, 08:00].
  4. 4.Post-experience, Johnson reported feeling "childlike," with a renewed sense of excitement, improved humor, and a significantly altered, less ego-driven approach to relational conflict, indicating a persistent change in his DMN [10:50, 11:42, 12:18].
  5. 5.Johnson subjectively rates 5-MeO-DMT as "more efficacious than all of them in terms of the reset of me as a human" compared to other longevity interventions like diet, exercise, and sauna [17:40].
  6. 6.He acknowledges serious risks of psychedelics (psychosis, bad trips, dramatic life changes), attributing them partly to unquantified, unsupervised use and advocating for rigorous, professional, and carefully structured approaches [16:14, 19:18].
  7. 7.Johnson views "psychoflexibility" derived from psychedelics as a potential asset for humans to adapt to rapid change driven by AI, suggesting it can shift from a liability to an advantage [22:19].
  8. 8.He is actively exploring "next-gen" longevity therapies, including mitochondrial augmentation therapy, gene therapy (foxil 3 expression), and testing drugs on his own lab-grown "Bryan Johnson organoids" [26:25, 29:29, 30:29].
  9. 9.Johnson believes psychedelics play a unique role in fostering a "youthful disposition of a can do attitude" and providing "30 40 years of psychological rejuvenation," which other therapies cannot achieve [35:48, 36:20].
  10. 10.The episode raises profound philosophical questions about personal identity, value changes, and whether one remains the "same person" after such dramatic neural rewiring [20:18, 21:19].

💡 Key Concepts Explained

5-MeO-DMT

Described as the most powerful psychedelic on the planet, 5-10 times more potent than DMT. Bryan Johnson used it as a longevity experiment, reporting an experience of "raw consciousness and raw intelligence" and profound "unimaginable bliss and euphoria."

Default Mode Network (DMN)

The brain's neural network responsible for constructing self and ego, and for rumination. Johnson explains that psychedelics like psilocybin dampen it, while 5-MeO-DMT "completely dissolves" it, leading to increased neuroplasticity and a more childlike state.

Neuroplasticity

The brain's ability to reorganize itself by forming new neural connections. In the context of psychedelics, it is driven by the dampening or dissolution of the DMN, allowing for new behaviors, ways of thinking, and potentially resolving trauma by rewiring brain connections.

Project Blueprint

Bryan Johnson's comprehensive longevity project, initiated five years ago. It systematically identifies and implements interventions with the best scientific evidence for health and anti-aging, including traditional practices and experimental therapies like psychedelics.

Psychoflexibility

A term used to describe the capacity for rapid personal change and adaptation. Johnson suggests that psychedelics can enhance psychoflexibility, making it a valuable asset for humans to navigate a world increasingly dominated by AI and accelerating change.

⚡ Actionable Takeaways

  • Approach powerful psychedelics like 5-MeO-DMT with extreme caution, ensuring it is done properly with a licensed professional in the right state, as Bryan Johnson warns against casual use due to inherent risks [15:13].
  • Prioritize understanding and measuring your body's baseline, including brain activity, to quantify the effects of any longevity or therapeutic intervention, mirroring Johnson's rigorous data-driven approach [13:10].
  • Reflect on the role of your 'default mode network' (DMN) in shaping your perception and consider practices that might promote neuroplasticity, such as meditation or mindfulness, to avoid becoming rigid in thought patterns [06:05].
  • Cultivate "psychoflexibility"—the ability to change and adapt rapidly—as Johnson suggests this will be an increasing asset for humans navigating an AI-dominated future [22:19].
  • Consider how internal unhappiness can drive external conflict, as Johnson suggests improving personal health and well-being could lead to a more positive, "can do attitude" in society [34:32].
  • Investigate emerging "next-gen" longevity therapies like mitochondrial augmentation or gene therapy as they evolve, but recognize they are in early stages and require careful, informed research [26:25, 29:29].
  • Seek out social groups and partners who are supportive and encouraging of personal growth and exploration, rather than those who try to "claw you back," as Johnson highlights the importance of such a network for his endeavors [24:22].

⏱ Timeline Breakdown

00:00Bryan Johnson introduces his recent 5-MeO-DMT experience for longevity.
01:00Johnson explains choosing psychedelics as a longevity experiment, following psilocybin trials that showed a "metabolic reset."
02:01He begins to describe the ineffable experience of 5-MeO-DMT as "raw consciousness and raw intelligence."
03:03Johnson details the rapid onset and non-visual nature of the 5-MeO-DMT experience, which hits within 10 seconds.
04:03He describes the critical choice to "relent and say yes" to the experience, which led to "unimaginable bliss and euphoria."
05:04Discussion on the dissolution of the ego and the experience being the "most dynamic" of his life.
06:05Explanation of the Default Mode Network (DMN) and how 5-MeO-DMT completely dissolves it.
07:05Analogy of the brain as airports with changing traffic patterns due to psychedelics, driving neuroplasticity.
08:06Connection of neuroplasticity to trauma resolution and the unexpected "metabolic reset" observed from psilocybin.
09:07Comparing 5-MeO-DMT to psilocybin, noting 5-MeO "annihilated" his DMN.
10:08Johnson describes feeling "childlike" after the experience, with renewed excitement and the return of laughter in dreams.
11:09Personal anecdotes of persistent DMN shifts, including improved communication and humor in daily interactions.
12:09Previous therapeutic use of ketamine during a life rebuilding phase, noting it was "little league relative to 5-MeO."
13:10Plans for extensive brain mapping (MRI, kernel, EEG) to quantify 5-MeO-DMT's neurological effects.
14:11Past psilocybin data showed "dramatic restoration of youthful brain patterns."
15:13Johnson's strong encouragement for psychedelics in longevity, emphasizing cautious, professional use.
16:14Addressing risks like permanent psychosis and bad trips, attributing them to unquantified, unsupervised use.
17:15Subjective comparison: 5-MeO-DMT was more efficacious than all other longevity therapies for "reset of me as a human."
18:15Discussion on the risks of dramatic life changes post-psychedelics (quitting jobs, divorcing family).
19:18Acknowledging investors' concerns about founders using psychedelics and his own increased motivation post-experience.
20:18Philosophical question: "Am I the same person?" after profound neural rewiring.
21:19Discussion on changing values and the potential for psychedelics to become an asset for human adaptation to AI-driven change.
22:19Johnson's "psychoflexibility" and openness to extreme changes like neural implants or transgenic systems.
23:21The source of his proclivity for frontier play, possibly an "overcompensation of trauma response."
24:22Balancing personal exploration with "external responsibility" to his children and his supportive social group.
25:23Other "next-gen" longevity modalities on the horizon, including cell and gene therapy.
26:25Discussion of mitochondrial augmentation therapy and plans to undergo it soon.
27:25Sourcing young mitochondria from a sister's child and creating a "family project" for longevity.
28:27Plans for mitochondrial transplantation and potential measurement via sprinting scores.
29:29Interest in gene therapy using plasmids for tissue regeneration, specifically foxil 3 expression, and reaching out to a Chinese professor.
30:29Plans to create "Bryan Johnson organoids" (heart, liver, lungs) from IPSCs to test drugs in vitro.
31:31Discussing challenges of Yamanaka factors (dosing, cancer risk) and cellular switches as a solution.
32:31Viewing GLP-1s as a "first big drop" in longevity, with gene/factor therapies as the "second" in terms of impact.
33:32The societal impact of abundance in longevity and health on reducing internal unhappiness and external conflict.
34:32Why continue with psychedelics? Their unique role in "youthfulness of your disposition towards reality" and "psychological rejuvenation" for the brain.
35:32The unique benefit of psychedelics in restoring a "can do attitude" and "childlike state" not achieved by other interventions.
36:33Closing remarks, acknowledging the unique power of psychedelics and Johnson's ongoing journey.

💬 Notable Quotes

"You basically experience raw consciousness and raw intelligence." [02:29]
"This is without question the most dynamic experience I've ever experienced as a human." [05:01]
"It completely dissolves your default mode network." [06:07]
"This was more efficacious than all of them in terms of the reset of me as a human. It just is incomparable." [17:40]
"I mean I felt like it was like 30 40 years of psychological rejuvenation, you know, it's like to transport me back to a childlike state." [36:20]

More from this guest

Bryan Johnson

Listen to Full Episode

📬 Get weekly summaries like this one

No spam. Unsubscribe anytime. By subscribing you agree to our Privacy Policy.